Product information

Current status:

Cancelled Pre Market

Current status date:

2023-01-19

Original market date: ^{See footnote 1}

Product name:

RIVAROXABAN

DIN:

02518899 Electronic product monograph is not available

Company:

BAYER INC
2920 Matheson Blvd East
Mississauga
Ontario
Canada L4W 5R6

Class:

Human

Dosage form(s):

Granules For Suspension

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

Prescription

American Hospital Formulary Service (AHFS): ^{See footnote 3}

20:12.04.14 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

B01AF01 RIVAROXABAN

Active ingredient group (AIG) number:^{See footnote5}

0152487007